July 28 is World Hepatitis Day

Time to introduce our new PEPperCHIP® Hepatitis B Virus Proteome Microarray!

World Hepatitis Day: Introducing the HBV Proteome MicroarraysHepatitis B is one of the most frequent infectious diseases with about 240 million chronically infected patients worldwide. Despite the availability of vaccines against Hepatitis B virus, about 750,000 people die of hepatitis B each year, about 300,000 of them due to liver cancer.

 

This raises an urgent need for improved vaccines with lower non- or low responder rates, since only 85-95% of vaccinated individuals have protective levels of antibody. Furthermore, improved treatment options for chronically infected patients are required. With our new PEPperCHIP® Hepatitis B Virus Proteome Microarray, we introduce a new R&D tool to address these topics.

 

The new PEPperCHIP® Hepatitis B Virus Proteome Microarray enables you to:

 

  • Improve vaccines for reduced number of low/non-responders
  • Identify and develop protective antibodies after liver transplantation
  • Monitor personalized antibody responses and immune profiles

 

The PEPperCHIP® Hepatitis B Virus Proteome Microarray further enables a proteome-wide epitope mapping of anti-HBV antibodies and patient sera against HBV genotypes (A-H) in a single assay!

 

For more information on the peptide microarray content of the new PEPperCHIP® Hepatitis B Virus Proteome Microarray, we invite you to download the material data sheet as well as the microarray layout scheme.